: Effectiveness and pharmacokinetics of indomethacin in premature newborns with patient ductus arteriosus.
2019 May;98(20):e15742. : Plasma indomethacin levels in preterm newborn infants with symptomatic patient ductus arteriosus — clinical and echocardiographic assessments of response. : Comparative bioavailability: Influence of various diets on the bioavailability of indomethacin. Journal of Obstetrics and Gynecology 44: 787–792 (1974).Department of Physical Medicine T2002, Rigshospitalet, University Hospital, 18 Tagenovej, DK-2200, Copenhagen, DenmarkYou can also search for this author in
: The fate of rectally administered radioactive indomethacin in human subjects: A preliminary report. 1986 Mar-Apr;11(2):87-106. doi: 10.2165/00003088-198611020-00001.Morris CA, Duparc S, Borghini-Fuhrer I, Jung D, Shin CS, Fleckenstein L.Malar J. Methods. In 8 other normal subjects and in 5 patients a 50-mg oral dose of indomethacin was given and the indomethacin concentration was followed from 8 to 32 hr after dosing. Journal of Chromatography 114: 483–485 (1975).Sylvälahti, E.K.G. ; McMahon, F.G. and Duggan, D.E.
Plasma concentrations of indomethacin have been studied in 5 healthy volunteers after single and multiple doses (25 mg intravenously [iv], 25, 50, and 100 mg orally, 100 mg rectally, and 25 mg three times daily [tid]. Ductal closure in utero by a prostaglandin synthetase inhibitor. : Pharmacokinetics of indomethazine and metabolites of indomethazine continuously applied in patients with healthy and damaged kidneys. The half-life of the beta-phase varied between 2.6 and 11.2 hr. 1. and Kwan, K.C. Journal of Pharmacokinetics and Biopharmaceutics 4: 255–280 (1975).Lindquist, B.; Jensen, K.M. : Prostaglandins as mediators of hypercalcemia associated with certain types of cancer. ; Windholz, T.B. ; Buchannan, W.W. and Rhymer, A.R. and Jansen, J.A. Indomethacin (l-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid) is an anti-inflammatory antipyretic drug commonly used for symptomatic relief of pain and stiffness in rheumatic diseases. 2014 May-Jun;28(3):793-8. doi: 10.1111/jvim.12345. ; Famaey, J.P. and Dick, W.C.: The clinical significance of the indomethacin-probenecid interaction. ; Van Den Heuvel, W.J.A. ; Hooke, K.F. ; Baty, J.D.
and Risley, E.A. Annals of the Rheumatic Diseases 32: 433–435 (1973).Emori, H.W. Clinical Pharmacology and Therapeutics 23: 658 (1978).Reinicke, C.; Hippius, N.; Berles, R. et al. : Effects of concomitant aspirin administration on the pharmacokinetics of indomethacin in man. Renal failure does not affect the serum concentrations of indomethacin.
; Jordan, R.L. Journal of Chromatography 117: 167–173 (1976).Helleberg, L.; Gylding-Sabroe, J. and Sylvest, J.: The effect of aspirin on the physiological disposition of indomethacin in man. ; Hill, D.E. ; Nuss, G.W.
and Steen, B.: Convulsions in a breast-fed infant after maternal indomethacin. Clinical Pharmacology and Therapeutics 15: 247–252 (1974).Lockie, L.M. ; Baber, N.; Chan, K. and Orme, M.: Quantitative gas-liquid Chromatographic method for the determination of indomethacin in biological fluids. A double-blind study utilizing indomethacin plasma levels.
Tissue Reactions 1: 173 (1979).Rothermich, N.O. European Journal of Clinical Pharmacology 4: 119–124 (1972).Jensen, K.M. ): 73–79 (1979).Jeremy, R. and Towson, J.: Interaction of aspirin and indomethacin in the treatment of rheumatoid arthritis.
; Simkin, P.A. : Interaction of indomethacin and acetylsalicylic acid as shown by the serum concentrations of indomethacin and salicylate.